share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mathias Sheila

SEC announcement ·  Jan 31 16:28
Summary by Moomoo AI
Virpax Pharmaceuticals, Inc. (VRPX) has reported a transaction involving Chief Scientific Officer Sheila Mathias. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Mathias after the transaction was not provided. This information is typically relevant for investors to assess the confidence of company insiders in the firm's prospects.
Virpax Pharmaceuticals, Inc. (VRPX) has reported a transaction involving Chief Scientific Officer Sheila Mathias. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Mathias after the transaction was not provided. This information is typically relevant for investors to assess the confidence of company insiders in the firm's prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more